Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy

Acta Oncologica

Volumn 47, Issue 5, 2008, Pages 835-842

  Nesvold, Inger Lise ^a   Dahl, Alv A ^b   Løkkevik, Erik ^a   Marit Mengshoel, Anne ^c   Fosså, Sophie D ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; TAMOXIFEN;

ARM DISEASE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; ARM; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SHOULDER; TIME FACTORS;

EID: 45849149316     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801961257     Document Type: Article

References (23)

1. Lemieux J, Bordeleau LJ, Goodwin PJ. Medical, psychosocial, and health-related quality of life issues in breast cancer survivors. In: Chang AE, Ganc P, Hayes DF, et al, editors. Oncology an evidence-based approach. New York: Springer Science and Business Media; 2006. p. 1836-58.
2. Kwan W, Jackson J, Weir LM, Dingee C, McGregor Greg, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life. J Clin Oncol 2002;20:4242-8.
3. Nagel PHAF, Bruggink EDM, Wobbes T, Strobbe LJA. Arm morbidity after complete axillary lymph node dissection for breast cancer. Acta Chir Belg 2003;103:212-6.
4. Haid A, Köberle-Wührer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation. Breast Cancer Res Treat 2002;73:31-6.
5. Meek AG. Breast radiotherapy and lymphedema. Review. Cancer 1998;83:2788-97.
6. Schunemann H, Willich N. Lymphödeme nach Mammacarzinom Eine Studie uber 5868 Fälle. (Lymphedema after treatment of cancer of the breast.) (In German with English abstract). Deutsch Med Wschr 1997;122:536-41.
7. Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 1996;74:2024-31.
8. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer. A three year follow-up study Q J M 2005;98:343-8.
9. Gerber L, Lampert M, Wood C, Duncan M, D'Angelo T, Schain W, et al. Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 1992;21:139-45.
10. Ernst MF, Voogd AC, Balder W, Klinkenbijl JHG, Roukema JA. Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 2002;79:151-5.
11. Sugden EM, Rezvani M, Harrison JM, Hughes LK. Shoulder movement after the treatment of early stage breast cancer. Clin Oncol 1998;10:173-81.
12. Lauridsen MC, Christiansen P, Hessov IB. The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: A randomised study. Acta Oncol 2005;44:449-57.
13. Johansen J, Overgaard J, Blichert Toft M, Overgaard M. Treatment morbidity associated with the management of the axilla in breast-conserving therapy. Acta Oncol 2000;39:349-54.
14. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Kreienberg R, et al. Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000;64:275-86.
15. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper- extremity volume estimates: Comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 2003;83:134-45.
16. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage; 2001.
17. Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, Cooke AL. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys 2007;67:841-6.
18. Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol 2007;46:1138-42.
19. Powell SN, Taghian AG, Kachnic LA, Coen JJ, Assaad SI. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003;55:1209-15.
20. Kiel KD, Rademacker AW. Early-stage breast cancer: Arm edema after wide excision and breast irradiation. Radiology 1996;198:279-83.
21. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: Risks in an era of dramatically changing axillary surgery. Breast J 2004;10:405-11.
22. Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M. Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 2000;39:393-7.
23. Bentzen SM, Overgaard AM, Thames HD. Fractionation sensitivity of a functional endpoint: Impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989;17:531-7.